Volume 45, Number 5, 740-743, DOI: 10.1007/s00125-002-0803-z

Published in partnership with the

Logo

European Association for the Study of Diabetes

A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes

K. Hara, K. Tobe, T. Okada, H. Kadowaki, Y. Akanuma, C. Ito, S. Kimura and T. Kadowaki

View Related Documents

Abstract

Aims/hypothesis. Peroxisome proliferator activated receptor % coactivator-1 (PGC-1), a transcriptional coactivator of the nuclear receptor PPAR%, plays a role in adaptive thermogenesis and insulin sensitivity. Plasma fasting insulin has been linked to the chromosomal region where the PGC-1 gene is located. Thus, PGC-1 can be viewed as a functional and positional candidate for the susceptibility gene for Type II (non-insulin-dependent) diabetes mellitus.

Methods. After screening the PGC-1 gene for single nucleotide polymorphisms (SNPs), we performed an association study using the newly detected SNPs in 537 Type II diabetic patients and 417 non-diabetic subjects.

Results. We found three relatively frequent SNPs in the PGC-1 gene (IVS4-11T > C, Thr394Thr and Gly482Ser). There were significant differences in fasting insulin (Gly/Gly; 37.7 - 1.43, Gly/Ser; 40.2 - 1.21, Ser/Ser; 44.3 - 1.82 pmol/l, p = 0.018) and insulin resistance index (Gly/Gly; 1.48 - 0.06, Gly/Ser; 1.56 - 0.05, Ser/Ser; 1.75 - 0.08, p = 0.027) according to the genotype of the Gly482Ser polymorphism. The Thr394Thr - Gly482Ser haplotype was associated with Type II diabetes (p = 0.00003).

Conclusion/interpretation. The results of this study suggested that the PGC-1 gene might be implicated in the pathogenesis of Type II diabetes.

Fulltext Preview

Image of the first page of the fulltext document